First Time Loading...
H

Hillevax Inc
NASDAQ:HLVX

Watchlist Manager
Hillevax Inc
NASDAQ:HLVX
Watchlist
Price: 12.67 USD -1.71% Market Closed
Updated: May 29, 2024

Hillevax Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hillevax Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
H
Hillevax Inc
NASDAQ:HLVX
Additional Paid In Capital
$655m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.7B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$6.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.3B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$11.9B
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
18%

See Also

What is Hillevax Inc's Additional Paid In Capital?
Additional Paid In Capital
655m USD

Based on the financial report for Dec 31, 2023, Hillevax Inc's Additional Paid In Capital amounts to 655m USD.

What is Hillevax Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 1Y
23%

Over the last year, the Additional Paid In Capital growth was 23%.